The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Open accessAbstract
In the last decade, optimized treatment for non-small cell lung cancer had lead to improved prognosis, but the overall survival is still very short. To further understand the molecular basis of the disease we have to identify biomarkers related to survival. Here we present the development of an online tool suitable for the real-time meta-analysis of published lung cancer microarray datasets to identify biomarkers related to survival. We searched the caBIG, GEO and TCGA repositories to identify samples with published gene expression data and survival information. Univariate and multivariate Cox regression analysis, Kaplan-Meier survival plot with hazard ratio and logrank P value are calculated and plotted in R. The complete analysis tool can be accessed online at: www.kmplot.com/lung. All together 1,715 samples of ten independent datasets were integrated into the system. As a demonstration, we used the tool to validate 21 previously published survival associated biomarkers. Of these, survival was best predicted by CDK1 (p<1E-16), CD24 (p<1E-16) and CADM1 (p = 7E-12) in adenocarcinomas and by CCNE1 (p = 2.3E-09) and VEGF (p = 3.3E-10) in all NSCLC patients. Additional genes significantly correlated to survival include RAD51, CDKN2A, OPN, EZH2, ANXA3, ADAM28 and ERCC1. In summary, we established an integrated database and an online tool capable of uni- and multivariate analysis for in silico validation of new biomarker candidates in non-small cell lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Funnel plots for detecting bias in meta-analysis
Sterne, J. A. C., & Egger, M. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00377-8 · Cited by 3,779
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
Pignon, J.-P., Tribodet, H., Scagliotti, G. V., Douillard, J.-Y., Shepherd, F. A., Stephens, R. J., Dunant, A., Torri, V., Rosell, R., Seymour, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9030 · Cited by 2,642 · cited 1×
“A previous meta-analysis of all the trials investigating chemotherapy benefit demonstrated a 5% improvement in overall survival [28].”
MethodBhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,576
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
Bild, A. H., Yao, G., Chang, J. T., Wang, Q., Potti, A., Chasse, D., Joshi, M.-B., Harpole, D., Lancaster, J. M., Berchuck, A., et al. (2006) · Nature · doi:10.1038/nature04296 · Cited by 2,032
Gene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025 · cited 1×
“While numerous individual genes associated with survival have been published in the last thirty years, new microarray-based multigene molecular prognostic models using genomic signatures have only emerged in the last ten years [3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19].”
BackgroundDirector's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma (2008) · Nature Medicine · doi:10.1038/nm.1790 · Cited by 1,190
Dawood, S., Broglio, K., Buzdar, A. U., Hortobagyi, G. N., & Giordano, S. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9844 · Cited by 758
Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction
Hou, J., Aerts, J., den Hamer, B., van IJcken, W., den Bakker, M., Riegman, P., van der Leest, C., van der Spek, P., Foekens, J. A., Hoogsteden, H. C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010312 · Cited by 755
Lung Cancer Incidence in Never Smokers
Wakelee, H. A., Chang, E. T., Gomez, S. L., Keegan, T. H., Feskanich, D., Clarke, C. A., Holmberg, L., Yong, L. C., Kolonel, L. N., Gould, M. K., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.2983 · Cited by 608
Lung cancer: New biological insights and recent therapeutic advances
Ramalingam, S. S., Owonikoko, T. K., & Khuri, F. R. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20102 · Cited by 471
Zhu, C.-Q., Ding, K., Strumpf, D., Weir, B. A., Meyerson, M., Pennell, N., Thomas, R. K., Naoki, K., Ladd-Acosta, C., Liu, N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.4325 · Cited by 471
Brabender, J., Danenberg, K. D., Metzger, R., Schneider, P. M., Park, J., Salonga, D. S., Hölscher, A. H., & Danenberg, P. V. (2001) · PubMed · Cited by 452
Gene Expression Signatures for Predicting Prognosis of Squamous Cell and Adenocarcinomas of the Lung
Raponi, M., Zhang, Y., Yu, J., Chen, G., Lee, G., Taylor, J. M. G., MacDonald, J., Thomas, D., Moskaluk, C., Wang, Y., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1191 · Cited by 435
Botling, J., Edlund, K., Lohr, M., Hellwig, B., Holmberg, L., Lambe, M., Berglund, A., Ekman, S., Bergqvist, M., Pontén, F., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1139 · Cited by 359
A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer
Lu, Y., Lemon, W., Liu, P.-Y., Yi, Y., Morrison, C., Yang, P., Sun, Z., Szoke, J., Gerald, W. L., Watson, M., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030467 · Cited by 323
Hayes, D. N., Monti, S., Parmigiani, G., Gilks, C. B., Naoki, K., Bhattacharjee, A., Socinski, M. A., Perou, C., & Meyerson, M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1748 · Cited by 314
ERCC1 Expression Is a Predictor of Survival in Resected Patients With Non-small Cell Lung Cancer
Simon, G. R., Sharma, S., Cantor, A., Smith, P., & Bepler, G. (2005) · Chest · doi:10.1378/chest.127.3.978 · Cited by 277
Lee, E.-S., Son, D.-S., Kim, S.-H., Lee, J., Jo, J., Han, J., Kim, H., Lee, H. J., Choi, H. Y., Jung, Y., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4937 · Cited by 265
Yamauchi, M., Yamaguchi, R., Nakata, A., Kohno, T., Nagasaki, M., Shimamura, T., Imoto, S., Saito, A., Ueno, K., Hatanaka, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043923 · Cited by 199
Zhan, P., Wang, J., Lv, X.-J., Wang, Q., Qiu, L.-X., Lin, X.-Q., Yu, L.-K., & Song, Y. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a97e31 · Cited by 192
Osteopontin expression in lung cancer
Chambers, A. F., Wilson, S. M., Kerkvliet, N., O'Malley, F. P., Harris, J. F., & Casson, A. G. (1996) · Lung Cancer · doi:10.1016/0169-5002(95)00595-1 · Cited by 189
Qiao, G.-B., Wu, Y.-L., Yang, X.-N., Zhong, W.-Z., Xie, D., Guan, X.-Y., Fischer, D., Kolberg, H.-C., Kruger, S., & Stuerzbecher, H.-W. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602665 · Cited by 186
Trikalinos, T. A., Salanti, G., Zintzaras, E., & Ioannidis, J. P. A. (2008) · Advances in genetics · doi:10.1016/s0065-2660(07)00413-0 · Cited by 166
Xie, Y., Xiao, G., Coombes, K. R., Behrens, C., Solis, L. M., Raso, G., Girard, L., Erickson, H. S., Roth, J., Heymach, J. V., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0196 · Cited by 162
Cigarette smoking and pancreas cancer: A case-control study of the search programme of the IARC
Boyle, P., Maisonneuve, P., Bueno-de-Mesquita, B. H., Ghadirian, P., Howe, G. R., Zatoński, W. A., Baghurst, P., Moerman, C. J., Simard, A., Miller, A. B., et al. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960703)67:1<63::aid-ijc12>3.0.co;2-d · Cited by 152
Lu, C. S., Soria, J., Tang, X., Xu, X.-C., Wang, L., Mao, L., Lotan, R., Kemp, B. L., Bekele, B. N., Feng, L., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.091 · Cited by 151
Ferreira, C. G., van der Valk, P., Span, S. W., Ludwig, I., Smit, E. F., Kruyt, F. A. E., Pinedo, H. M., van Tinteren, H., & Giaccone, G. (2001) · PubMed · Cited by 126
Jin, M., Inoue, S., Umemura, T., Moriya, J., ARAKAWA, M., Nagashima, K., & Kato, H. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00225-2 · Cited by 112
Győrffy, B., Molnar, B. A., Lage, H., Szállási, Z., & Eklund, A. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005645 · Cited by 104
Self-citationConstructing Molecular Classifiers for the Accurate Prognosis of Lung Adenocarcinoma
Guo, L., Ma, Y., Ward, R., Castranova, V., Shi, X., & Qian, Y. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2336 · Cited by 104
Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma
Liu, Y., Xiao, Z., Li, M., Li, M., Zhang, P., Li, C., Li, F., Chen, Y., Yi, H. L., Yao, H., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2429 · Cited by 102
Győrffy, B., Benke, Z., Lánczky, A., Balázs, B., Szállási, Z., Tı́már, J., & Schäfer, R. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1676-y · Cited by 98
Self-citationEnhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer
Huqun, Ishikawa, R., Zhang, J., Miyazawa, H., Goto, Y., Shimizu, Y., Hagiwara, K., & Koyama, N. (2011) · Cancer · doi:10.1002/cncr.26441 · Cited by 95
Lee, H. J., Choe, G., Jheon, S., Sung, S. W., Lee, C., & Chung, J.-H. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d5e554 · Cited by 94
Zhang, L. Q., Wang, J., Jiang, F., Xu, L., Liu, F. Y., & Yin, R. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034100 · Cited by 63
Xi, L., Lyons‐Weiler, J., Coello, M. C., Huang, X., Gooding, W. E., Luketich, J. D., & Godfrey, T. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2525 · Cited by 59
Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma.
Tsuna, M., Kageyama, S., Fukuoka, J., Kitano, H., Doki, Y., Tezuka, H., & Yasuda, H. (2009) · PubMed · Cited by 39
Zhang, L. Q., Jiang, F., Xu, L., Wang, J., Bai, J., Yin, R. H., Wu, Y. Q., & Meng, L. J. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.10.003 · Cited by 29
Interferon (Alpha, Beta and Omega) Receptor 2 Is a Prognostic Biomarker for Lung Cancer
Tanaka, S., Hattori, N., Ishikawa, N., Horimasu, Y., Deguchi, N., Takano, A., Tomoda, Y., Yoshioka, K., Fujitaka, K., Arihiro, K., et al. (2012) · Pathobiology · doi:10.1159/000331230 · Cited by 15
Cited by
Chromosomal instability drives metastasis through a cytosolic DNA response
Bakhoum, S. F., Ngo, B., Laughney, A. M., Cavallo, J.-A., Murphy, C. J., Ly, P., Shah, P., Sriram, R. K., Watkins, T. B. K., Taunk, N. K., et al. (2018) · Nature · doi:10.1038/nature25432 · Cited by 1,593
Zilionis, R., Engblom, C., Pfirschke, C., Savova, V., Zemmour, D., Saatcioglu, H. D., Krishnan, I., Maroni, G., Meyerovitz, C. V., Kerwin, C. M., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.009 · Cited by 1,475
PI3Kγ is a molecular switch that controls immune suppression
Kaneda, M. M., Messer, K. S., Ralainirina, N., Li, H., Leem, C. J., Gorjestani, S., Woo, G., Nguyen, A. V., Figueiredo, C. C., Foubert, P., et al. (2016) · Nature · doi:10.1038/nature19834 · Cited by 1,173
cGAS is essential for cellular senescence
Yang, H., Wang, H., Ren, J., Chen, Q., & Chen, Z. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705499114 · Cited by 1,009
Szász, A. M., Lánczky, A., Nagy, Á., Förster, S., Hark, K., Green, J. E., Boussioutas, A., Busuttil, R., Szabó, A., & Győrffy, B. (2016) · Oncotarget · doi:10.18632/oncotarget.10337 · Cited by 988
Self-citation
Metadata
- Authors
- Győrffy, B., Surowiak, P., Budczies, J., & Lánczky, A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-12-18
- Volume
- 8
- Issue
- 12
- Pages
- e82241
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2126496132
- Cited by
- 1,760
- References
- 41
- FWCI
- 39.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.